Latest California Healthline Stories
California Consumers Face More Immediate Concerns Than Obamacare’s Uncertain Future
California Healthline’s senior correspondent Chad Terhune joined Peter Lee, executive director of Covered California, on KPCC radio’s “Air Talk” to discuss the open enrollment season and the ongoing frustration over big premium increases and narrow provider networks.
California Hopes $3 Billion Experiment Will Improve Health Of Neediest
Pilot projects are being launched in 18 counties to reduce ER visits among Medi-Cal’s most costly patients.
Amid Sign-Up Surge, Covered California Extends Enrollment Deadline
Despite health law uncertainty, more than 25,000 new consumers chose new plans in just two days this week.
How Would Repeal Of The ACA Affect Californians’ Health Coverage?
Our interactive map gives a county-by-county look at the percentage of people covered by Covered California and Medi-Cal expansion.
California Lawmakers Aim To Pay Dentists More To Treat Poor Patients
Legislation would raise payments for Denti-Cal providers, using revenue from the state tobacco tax recently passed by California voters.
Many Parents With Job-Based Coverage Turn To Medicaid, CHIP To Insure Kids
Researcher says the reliance on public programs is a lesson for lawmakers who will be considering renewing CHIP next year.
Leading the Way? Bay Area Cities To Embark On Soda Tax Spending
Health advocates are expecting millions in new tax money for health education programs aimed at preventing obesity, diabetes and tooth decay. Other cities around the country are mulling similar measures.
Slowing Down Hospital Discharge Requires Fast Action
Seniors who feel they’re being rushed out of the hospital can file an appeal to halt the process but they need to act fast.
Drug Price Transparency Before California Lawmakers Again
California should continue to “poke the bear” on drug price policy, Senate Health Committee chairman says.
Need Pricey Drugs From An Obamacare Plan? You May Shoulder More Of The Cost
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014. California has greater protections to limit consumer costs.